Profile
Leigh Zawel worked as a Managing Director at MPM BioImpact, Inc. He was the Director of Cancer Biology at Sanofi España SA from 1999 to 2010.
From 2017 to 2022, he served as the Chief Scientific Officer-Small Molecules at Cullinan Oncology LLC and Cullinan Oncology, Inc. Zawel received his undergraduate degree from Rutgers State University of New Jersey and his graduate degree from the University of Wisconsin.
Former positions of Leigh Zawel
| Companies | Position | End |
|---|---|---|
Cullinan Oncology LLC
 Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2022-02-28 |
| CULLINAN THERAPEUTICS, INC. | Corporate Officer/Principal | 2022-02-28 |
| Sanofi España SA | Corporate Officer/Principal | 2009-12-31 |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Private Equity Investor | - |
Training of Leigh Zawel
| Rutgers State University of New Jersey | Undergraduate Degree |
| University of Wisconsin | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CULLINAN THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Finance |
| Sanofi España SA | |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Finance |
- Stock Market
- Insiders
- Leigh Zawel
